BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6690011)

  • 1. The value of serum copper levels in non-Hodgkin's lymphoma.
    Cohen Y; Epelbaum R; Haim N; McShan D; Zinder O
    Cancer; 1984 Jan; 53(2):296-300. PubMed ID: 6690011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum copper level in non-Hodgkin's lymphomas.
    Salvagno L; Pappagallo GL; Chiarion Sileni V; Segati R; Cartei G; Endrizzi L; Paccagnella A; Ongaro G; Bonvicini P; Fiorentino MV
    Tumori; 1982 Feb; 68(1):57-62. PubMed ID: 7071946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum copper levels in non-Hodgkin's lymphoma.
    Shah-Reddy I; Khilanani P; Bishop CR
    Cancer; 1980 Apr; 45(8):2156-9. PubMed ID: 6989485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of serum copper levels and erythrocyte sedimentation rates as indicators of disease activity in children with Hodgkin's disease.
    Wilimas J; Thompson E; Smith KL
    Cancer; 1978 Oct; 42(4):1929-35. PubMed ID: 709539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin's disease, non-Hodgkin's lymphoma, and nonmalignant lymphadenopathy.
    Margerison AC; Mann JR
    Cancer; 1985 Apr; 55(7):1501-6. PubMed ID: 3978543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of copper level in serum and routine laboratory parameters in estimation of outspreading of Hodgkin's lymphoma.
    Jamakovic M; Baljic R
    Med Arch; 2013; 67(3):185-7. PubMed ID: 23848039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study on serum copper and zinc levels and copper/zinc ratio in malignant lymphoma].
    Wu HY
    Zhonghua Zhong Liu Za Zhi; 1988 Sep; 10(5):335-8. PubMed ID: 3248498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of radiotherapy in control of stage I and II non-Hodgkin's lymphoma.
    Chen MG; Prosnitz LR; Gonzalez-Serva A; Fischer DB
    Cancer; 1979 Apr; 43(4):1245-54. PubMed ID: 445327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum copper and zinc levels and copper/zinc ratio in pediatric non-Hodgkin's lymphoma.
    Gözdaşoğlu S; Cavdar AO; Arcasoy A; Akar N
    Acta Haematol; 1982; 67(1):67-70. PubMed ID: 6800204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of histologic type on the incidence and duration of response in non-Hodgkin's lymphoma.
    Herrmann R; Barcos M; Stutzman L; Walsh D; Freeman A; Sokal J; Henderson ES
    Cancer; 1982 Jan; 49(2):314-22. PubMed ID: 7032683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of non-Hodgkin's lymphomas of 210 patients with nodular and favorable histologies--report of the Japanese Lymphoma Radiation Therapy Study Group].
    Hayabuchi N; Jinguu K; Masaki N; Horiuchi J; Niibe H; Morita K; Watanabe S; Kaneta K
    Gan No Rinsho; 1988 Apr; 34(5):589-98. PubMed ID: 3290531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic changes in red blood cells in malignant lymphomas.
    De Bellis R; Boulard MR; Kasdorf H; Rodriguez I; Ferrando R; Di Landro J; Ferrari M; Sanguinett CM; Tanzer J
    Br J Haematol; 1979 May; 42(1):35-9. PubMed ID: 465359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Hodgkin's lymphoma in children.
    Pinkel D; Johnson W; Aur RJ
    Br J Cancer Suppl; 1975 Mar; 2():298-323. PubMed ID: 1101924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum copper and zinc levels in patients with malignant neoplasm of the urogenital tract].
    Sanada S; Ogura K; Kiriyama T; Yoshida O
    Hinyokika Kiyo; 1985 Aug; 31(8):1299-316. PubMed ID: 4083194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of non-Hodgkin's lymphomas with nodular and favorable histologies, stages I and II.
    Paryani SB; Hoppe RT; Cox RS; Colby TV; Rosenberg SA; Kaplan HS
    Cancer; 1983 Dec; 52(12):2300-7. PubMed ID: 6416664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodular lymphoma: clinicopathologic correlations of parafollicular small lymphocytes and degree of nodularity.
    Colby TV; Hoppe RT; Burke JS
    Cancer; 1980 May; 45(9):2364-7. PubMed ID: 7379032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of the serum IL-2R level and Ga-67 scan findings in making a differential diagnosis between sarcoidosis and non-Hodgkin's lymphoma.
    Kita T; Watanabe S; Yano F; Hayashi K; Yamamoto M; Iwasaki Y; Kosuda S
    Ann Nucl Med; 2007 Nov; 21(9):499-503. PubMed ID: 18030581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Hodgkin's lymphoma in northern India. A retrospective analysis of 238 cases.
    Garg A; Dawar R; Agarwal V; Rustagi RK; Kochupillai V
    Cancer; 1985 Aug; 56(4):972-7. PubMed ID: 4016691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. So-called "Lennert's lymphoma": is it a clinicopathologic entity?
    Kim H; Nathwani BN; Rappaport H
    Cancer; 1980 Mar; 45(6):1379-99. PubMed ID: 6986978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Rappaport classification of non-Hodgkin's lymphomas: a closer look using other proposed classifications.
    Garvin AJ; Simon R; Young RC; DeVita VT; Berard CW
    Semin Oncol; 1980 Sep; 7(3):234-43. PubMed ID: 6998002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.